HomeFileCoronary disease

Coronary disease

ACC 2024 | PREVENT Study

The use of intravascular imaging to identify vulnerable plaque (VP) has proven to be very useful, as...

ACC 2024 | DanGer-Shock Trial

Cardiogenic shock will develop in approximately 10% of patients with ST elevated acute MI (STEMI), and unfortunately,...

Lithotripsy in the “Real World”: REPLICA EPIC-18 Study

Severe persistent calcification of the coronary arteries has been associated with different factors, such as advanced age,...

Physiologically Significant Obstructions in the Left Main Coronary Artery: Revascularizing vs. Deferring

Most randomized studies on revascularization in stable coronary artery disease exclude left main coronary artery disease (LMCAD)....

Virtual Flow Reserve (VFR): Virtual Physiological Test with OCT

Assessing intermediate coronary lesions with intracoronary physiology tests such as fractional flow reserve (FFR) or other non-hyperemic...

AGENT-IDE: Drug Coated Balloons for Instent Restenosis

Drug eluting stents (DES) have improved considerably over the years, reducing the initial indices of instent restenosis...

Rehospitalization After Treatment of Left Main Coronary Artery Disease and Its Prognosis: Sub-Analysis of the EXCEL Study

Individual randomized studies have shown variable results regarding the mortality risk following treatment of left main coronary...

ISCHEMIA Outcomes: Does Sex Have Any Impact?

We are well aware of CAD physiopathological disparities and how it manifests differently in men and women....